Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Dr. Beyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganResidency, Surgery, 2024 - 2031
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2024
Publications & Presentations
PubMed
- Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.Gabriella V Beyer, Sophia Hueser, Rachel Li, Deeraj Manika, Minhyuk Lee
Surgery. 2024-03-01 - 11 citationsEstablishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy.Catherine G Tran, Luis C Borbon, Jacqueline L Mudd, Ellen Abusada, Solmaz AghaAmiri
Cancers. 2022-04-10
Journal Articles
- Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitorsBeyer GV, Hueser S, Li R, Manika D, Lee M, Chan CHF, Howe JR, Ear PH, Surgery, 10/31/2023
- Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted TherapyTran CG, Borbon LC, Mudd JL, Abusada E, AghaAmiri S, Ghosh SC, Vargas SH, Li G, Beyer GV, McDonough M, Li R, Chan CHF, Walsh SA, Wadas TJ, O'Dorisio T, O'Dorisio MS, G..., Cancers (Basel), 4/10/2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
